Search results
Eisai initiates rolling Biologics License Application to US FDA for Leqembi® (lecanemab-irmb) for...
FOX 59 Indianapolis· 2 hours agoIn the US, Leqembi is indicated for the treatment of Alzheimer's disease (AD) in patients with Mild...
How Does Alzheimer’s Kill?
MedicineNet.com· 4 days agoAlzheimer's disease (AD) is a degenerative disease of the brain, resulting in memory loss, cognitive decline, and personality changes ...
Alzheimer’s biomarkers observed in young people with diabetes
MedicalNewsToday via AOL· 13 hours agoNew research shows that adolescents and young adults with type 1 or type 2 diabetes may be at higher...
Unauthorized Living Season 1 Streaming: Watch & Stream Online via Netflix
COMINGSOON.net via Yahoo News· 55 minutes agoThe show revolves around Nemo Bandeira, a powerful drug lord. After getting diagnosed with Alzheimer...
UPDATE 1-Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
Reuters via Yahoo Finance· 32 minutes agoEisai and partner Biogen said on Tuesday that the Japanese drugmaker has begun submitting data on a rolling basis to the US health regulator for a marketing application of a subcutaneous form ...
...Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast...
WJTV Jackson· 5 hours agoLEQEMBI is indicated for the treatment of Alzheimer's disease (AD) in patients with Mild Cognitive Impairment (MCI) or mild dementia ...
'I'm a Neurologist, and This Is My Go-To Dinner For Alzheimer's Prevention'
Parade via Yahoo News· 4 days agoNeurologist cooking dinner for Alzheimer's prevention Nearly 7 million Americans are living with ...
Halia Therapeutics to Unveil New Clinical Program Targeting the LRRK2 Protein for Alzheimer's ...
The Herald Journal· 17 hours agoCEO David J. Bearss, Ph.D., will be participating in a panel discussing the "Landscape of Drug Discovery and Impact of AI Discussion" on Wednesday, May 22, from 1:50 to 2:30
ProMIS Neurosciences Announces First Quarter 2024 Financial Results and Recent Highlights
Digital Journal· 9 hours agoTop-line data from first-in-human Phase 1a clinical trial of PMN310 as a treatment for Alzheimer’s disease on track for mid-2024CAMBRIDGE ...
LIVING WELL: New drug approved to treat Alzheimer’s Disease
FOX 16 Little Rock· 1 day agoThe FDA approved a new drug to treat Alzheimer’s Disease.